CompoAtlas

Bone Builder (tablet)

Bone Builder (tablet), licence 80031724: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Genuine Health Inc.
NPN or DIN-HM
80031724
Status
Active licence
Licence date
25 April 2012
Revision date
3 October 2013
Form
Comprimé
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Vitamine C

Source : Ascorbate de magnésium

6.6 mg19,800 µg
Manganèse

Source : manganese-enriched Saccharomyces cerevisiae

1.0 mg3,000 µg
Sélénium

Source : selenium-enriched Saccharomyces cerevisiae

33.3 mcg99.9 µg
Vitamine B12

Source : Cyanocobalamine

3.3 mcg9.9 µg
Zinc

Source : zinc-enriched Saccharomyces cerevisiae

3.3 mg9,900 µg
Acide (S)-2,6-diaminohexanoïque

Source : Monochlorhydrate de L-lysine

133.3 mgNot calculated
Vitamine C

Source : Ascorbate de calcium

26.6 mg79,800 µg
Cuivre

Source : Produit de chélation de composé cuivrique et de PVH

333.3 mcg999.9 µg

Non-medicinal ingredients

cellulose, Hypromellose, Croscarmellose de sodium, Saveur de vanille, Dioxyde de silicium, Acide stéarique, Glycérine, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
AdultesNot specified1.0 Comprimé3.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Calcium intake, when combined with sufficient vitamin D, a healthy diet and regular exercise, may reduce the risk of developing osteoporosis. Helps in the development and maintenance of bones and teeth and with the absorption and use of calcium and phosphorus. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) helps prevent bone loss / osteoporosis (in peri- and postmenaupausal women) (in later life). Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps in connective tissue formation. Helps in tissue formation. Helps to produce and repair connective tissue. Helps in wound healing. An antioxidant for the maintenance of good health. Helps to form red blood cells. A factor in the maintenance of good health. Helps to maintain proper muscle function. Helps to maintain immune function. Provides antioxidants for the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80031724

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2013. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

List recorded in 2013. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line